TRANSPLANTS FOR CHRONIC MYELOID-LEUKEMIA (CML) IN CHRONIC PHASE (CP) - THE EFFECT OF AGE

被引：0
|
作者：
PETERSEN, FB [1 ]
CLIFT, RA [1 ]
BUCKNER, CD [1 ]
机构：
[1] SEATTLE MARROW TRANSPLANT TEAM,SEATTLE,WA
来源：
EXPERIMENTAL HEMATOLOGY | 1991年 / 19卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：543 / 543
页数：1
相关论文
共 50 条
  • [31] TRANSPLANTATION REGIMENS FOR CHRONIC MYELOGENOUS LEUKEMIA (CML) IN CHRONIC PHASE (CP)
    CLIFT, RA
    BUCKNER, CD
    STORB, R
    THOMAS, ED
    EXPERIMENTAL HEMATOLOGY, 1988, 16 (06) : 501 - 501
  • [32] CHRONIC MYELOID-LEUKEMIA
    WOODRUFF, RK
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1981, 11 (06): : 678 - 686
  • [33] CHRONIC MYELOID-LEUKEMIA
    TURA, S
    BACCARANI, M
    ZACCARIA, A
    HAEMATOLOGICA, 1986, 71 (03) : 169 - 176
  • [34] DASATINIB IN CHILDREN AND ADOLESCENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML-CP) FROM A PHASE 2 TRIAL
    Zwaan, C. M.
    Kearns, P.
    Lee, M. L. D. M.
    De Souza, C. A.
    Bertrand, Y.
    Hijiya, N.
    Stork, L.
    Chung, N-G
    Cardos, R. Cardenas
    Saikia, T.
    Fagioli, F.
    Seo, J. J.
    Landman-Parker, J.
    Lancaster, D.
    Place, A. E.
    Rabin, K. R.
    Sacchi, M.
    Swanink, R.
    Gore, L.
    HAEMATOLOGICA, 2017, 102 : 150 - 151
  • [35] THE BCR BREAKPOINT AND CHRONIC PHASE DURATION IN CHRONIC MYELOID-LEUKEMIA
    STARK, RA
    WRIGHT, L
    BIGGS, JC
    KEARNEY, PP
    ACTA HAEMATOLOGICA, 1992, 88 (04) : 216 - 216
  • [36] Primary Results of the Phase 4 BYOND Study of Bosutinib for Pretreated Chronic Phase (CP) Chronic Myeloid Leukemia (CML)
    Gambacorti-Passerini, Carlo
    Abboud, Camille
    Gjertsen, Bjorn Tore
    Bruemmendorf, Tim
    Smith, B. Douglas
    Giraldo-Castellano, Pilar
    Stromberg, Ulla
    Saussele, Susanne
    Bardy-Bouxin, Nathalie
    Viqueira, Andrea
    Leip, Eric
    Leone, Jocelyn
    Rosti, Gianantonio
    Watts, Justin
    Giles, Frank
    Hochhaus, Andreas
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S290 - S290
  • [37] Primary results of the phase 4 BYOND study of bosutinib for pretreated chronic phase (CP) chronic myeloid leukemia (CML)
    Hochhaus, A.
    Gambacorti-Passerini, C.
    Saussele, S.
    Gjertsen, Tore B.
    Bruemmendorf, T. H.
    Abboud, C.
    le Coutre, P.
    Smith, B. D.
    Giraldo-Castellano, P.
    Stromberg, U.
    Bardy-Bouxin, N.
    Viqueira, A.
    Leip, E.
    Leone, J.
    Rosti, G.
    Watts, J.
    Giles, F.
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 129 - 130
  • [38] INTERFERONS IN THE MANAGEMENT OF CHRONIC MYELOID-LEUKEMIA DURING THE CHRONIC PHASE
    GUILHOT, F
    SEMAINE DES HOPITAUX, 1989, 65 (32): : 1969 - 1973
  • [39] SWEETS SYNDROME DURING THE CHRONIC PHASE OF CHRONIC MYELOID-LEUKEMIA
    LOPEZ, JLB
    FONSECA, E
    MANSO, F
    ACTA HAEMATOLOGICA, 1990, 84 (04) : 207 - 208
  • [40] IMMUNOPHENOTYPE OF CHRONIC MYELOID-LEUKEMIA BLASTIC PHASE
    LOPEZKARPOVITCH, X
    CARDENAS, MR
    PIEDRAS, J
    BLOOD, 1994, 84 (10) : A633 - A633
12345